Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 15;12(4):628.
doi: 10.3390/cells12040628.

Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer

Affiliations
Review

Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer

Deepshikha Mishra et al. Cells. .

Abstract

The cancer secretome reflects the assortment of proteins released by cancer cells. Investigating cell secretomes not only provides a deeper knowledge of the healthy and transformed state but also helps in the discovery of novel biomarkers. Secretomes of cancer cells have been studied in the past, however, the secretome contribution of stromal cells needs to be studied. Cancer-associated fibroblasts (CAFs) are one of the predominantly present cell populations in the tumor microenvironment (TME). CAFs play key role in functions associated with matrix deposition and remodeling, reciprocal exchange of nutrients, and molecular interactions and signaling with neighboring cells in the TME. Investigating CAFs secretomes or CAFs-secreted factors would help in identifying novel CAF-specific biomarkers, unique druggable targets, and an improved understanding for personalized cancer diagnosis and prognosis. In this review, we have tried to include all studies available in PubMed with the keywords "CAFs Secretome". We aim to provide a comprehensive summary of the studies investigating role of the CAF secretome on cancer development, progression, and therapeutic outcome. However, challenges associated with this process have also been addressed in the later sections. We have highlighted the functions and clinical relevance of secretome analysis in stromal CAF-rich cancer types. This review specifically discusses the secretome of stromal CAFs in cancers. A deeper understanding of the components of the CAF secretome and their interactions with cancer cells will help in the identification of personalized biomarkers and a more precise treatment plan.

Keywords: cancer; cancer associated fibroblasts; secretome; stroma; tumor conditioned medium; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Secretome: Advantages and limitations; (A) shows different diseases exploring the clinical relevance of secretome-based therapy; (B) addresses the advantages and limitation associated with the use of CAFs (cell specific) secretomes in cancer.
Figure 2
Figure 2
Features of CAFs secretome; (A) displays the process of fibroblast activation; (B) explains the diverse tumor-promoting features of the CAFs secretome.

Similar articles

Cited by

References

    1. Tjalsma H., Bolhuis A., Jongbloed J.D., Bron S., van Dijl J.M. Signal peptide-dependent protein transport in Bacillus subtilis: A genome-based survey of the secretome. Microbiol. Mol. Biol. Rev. 2000;64:515–547. doi: 10.1128/MMBR.64.3.515-547.2000. - DOI - PMC - PubMed
    1. Karagiannis G.S., Pavlou M.P., Diamandis E.P. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol. Oncol. 2010;4:496–510. doi: 10.1016/j.molonc.2010.09.001. - DOI - PMC - PubMed
    1. Xu R., Rai A., Chen M., Suwakulsiri W., Greening D.W., Simpson R.J. Extracellular vesicles in cancer-implications for future improvements in cancer care. Nat. Rev. Clin. Oncol. 2018;15:617–638. doi: 10.1038/s41571-018-0036-9. - DOI - PubMed
    1. Brown K.J., Seol H., Pillai D.K., Sankoorikal B.J., Formolo C.A., Mac J., Edwards N.J., Rose M.C., Hathout Y. The human secretome atlas initiative: Implications in health and disease conditions. Biochim. Biophys. Acta. 2013;1834:2454–2461. doi: 10.1016/j.bbapap.2013.04.007. - DOI - PMC - PubMed
    1. Song P., Kwon Y., Joo J.Y., Kim D.G., Yoon J.H. Secretomics to Discover Regulators in Diseases. Int. J. Mol. Sci. 2019;20:3893. doi: 10.3390/ijms20163893. - DOI - PMC - PubMed

Grants and funding

This work received no funding.

LinkOut - more resources

-